Posterior capsule rupture is most likely to occur at the stage of sculpting or quadrant removal, is affected by the presence ...
Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of ...
Alcon's Future Looks Fruitful as New Innovation and Commercial Execution Spark Market Outperformance
Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.
Bausch + Lomb has reported a “voluntary recall” of certain intraocular lenses (IOLs) on its enVista platform due to ...
Refractive cataract surgery has been transformed by advanced IOL technology, including extended and full-range vision lenses, ...
The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...
Bausch + Lomb has recalled its intraocular lenses after receiving reports of cases inflammation. The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular ...
Cataract extraction with intraocular lens insertion is associated with reduced odds of falls and major injuries in older ...
Bausch + Lomb (BLCO) announced a voluntary recall of intraocular lenses on its enVista platform. This action was taken out of an abundance of ...
As much as we believe in the enVista platform, patient safety will always be our number one priority,” said Brent Saunders, chairman and CEO, Bausch + Lomb. “Surgeons and patients trust Bausch + Lomb, ...
ALC secures CE Mark for Clareon Vivity IOL, bringing advanced presbyopia-correcting lens technology to Europe, enhancing ...
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results